New pharmacological treatments for obesity: incretin analogues, their mechanism of action, efficacy and safety Medicine Today Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet Switching from Semaglutide to Tirzepatide: Is It a Good Idea? Hubmed Recent advances in peptide based therapies for obesity and type 2 diabetes ScienceDirect Cagrilintide: What It Is and How It's Being Studied for Weight Loss For an adult with type 2 diabetes mellitus who requires substantial weight loss, what are the recommended use, dosing, regulatory approval status, and contraindications of tirzepatide compared with cagrilintide, and what alternative